Group Education Helps Smoking Cessation and Hypertension Control

Shanghai Jiao Tong University School of Medicine

Status: Not yet enrolling

Conditions: Hypertension; Smoking Cessation

Treatments: Behavioral: conventional smoking cessation management; Behavioral: group education

Study type: Interventional

Funder types: Other

Identifiers

NCT05530083

GESHC

Details and patient eligibility

About

Smoking elderly males with stage 1 and 2 hypertension who currently smoked at least one cigarette per day and were willing to quit smoke will be invited to this cluster randomized, controlled, interventional, open clinical trial. The investigators will provide participants with group education of smoking cessation and their blood pressure measured at clinic at the sixth month is the primary endpoint. The investigators aim to explore how group education of smoking cessation effects smoking cessation, hypertension control and cardiovascular events.

Enrollment: 2,000 estimated patients

Sex: Male

Ages: 65 to 84 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• signed the informed consent
• aged 65 to 84
• new-onset hypertension or poorly controlled hypertension (140mmHg≤systolic blood pressure<180mmHg and (or) 90mmHg≤ diastolic blood pressure<110mmHg)
• smoked last week and smoked more than 1 cigarette per day on average
• be willing to quit smoking
• can communicate normally and cooperate in blood pressure measurements, finishing questionnaires
• complete interventions and follow-up consistently

Exclusion criteria

• home systolic blood pressure<130mmHg and (or) home diastolic blood pressure<80 mmHg
• severe communication difficulties (aphasia, hearing impairment, etc.)
• suffering from mental disorders such as anxiety and depression
• cancer confirmed
• with previous serious cardiovascular events such as acute coronary syndrome, acute left heart failure, stroke or with specific cardiovascular therapeutic device such as pacemakers
• other serious physical illness or illness identified by investigators that unable to participant in study
• using specific non-permitted medication currently

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

2,000 participants in 2 patient groups

group education

Experimental group

Description:

The investigators will provide experimental groups with group education of smoking cessation, including lectures in groups of 50 to 100 people and panel discussion in groups of 5 to 10 people.

Treatment:

Behavioral: group education

conventional smoking cessation management

Other group

Description:

The investigators will provide control groups with conventional smoking cessation management, including regular follow-up of smoking status and giving advice of smoking cessation.

Treatment:

Behavioral: conventional smoking cessation management